Scarica l'app Stockscreener
10.21
2.82%
0.28
Dopo l'orario di chiusura:
10.20
-0.01
-0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$9.93
Aprire:
$9.98
Volume 24 ore:
4.78M
Relative Volume:
0.99
Capitalizzazione di mercato:
$2.05B
Reddito:
$3.68B
Utile/perdita netta:
$-627.00M
Rapporto P/E:
-3.2436
EPS:
-3.1477
Flusso di cassa netto:
$104.00M
1 W Prestazione:
+1.39%
1M Prestazione:
-16.11%
6M Prestazione:
-3.50%
1 anno Prestazione:
-35.58%
Intervallo 1D:
$9.97
$10.46
Intervallo di 1 settimana:
$9.405
$10.46
Portata 52W:
$9.405
$16.96
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
10.21 | 1.99B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Sell |
| 2026-02-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
Dentsply Sirona Shares In Focus As Nasdaq Futures Climb Higher - Kalkine Media
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Rating of "Hold" by Analysts - MarketBeat
Assessing Dentsply Sirona (XRAY) Valuation After Steep Share Price And Earnings Setbacks - Sahm
Registration opens for reimagined DS World Las Vegas - Dental Tribune US
CaviSense to demo caries detection tech at AAPD 2026 - DrBicuspid.com
Dentsply Sirona stock (US9839191015): Conference spotlight after Q1 update - AD HOC NEWS
Dentsply Sirona Inc stock (US24906P1093): dental specialist reacts to latest quarterly results - AD HOC NEWS
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference - GlobeNewswire
Dentsply Sirona stock hits 52-week low at $9.85 By Investing.com - Investing.com Nigeria
DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year LowHere's Why - MarketBeat
Dentsply Sirona stock hits 52-week low at $9.85 - Investing.com
Dental Implants and Prosthetics Market to Reach USD 39.05 - openPR.com
Dentsply Sirona Inc stock (US9839191015): dividend strength and macro pressure move into focus - AD HOC NEWS
Dentsply Sirona stock (US24906P1093): earnings update and strategic focus after latest quarter - AD HOC NEWS
Healthcare Stocks Decline After Hot April PPI Report on May 17, 2026News and Statistics - IndexBox
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know - Yahoo Finance
A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $10.5 to $17 - Moomoo
Dentsply Sirona stock (US24906P1093): dental specialist updates 2026 guidance after solid quarter - AD HOC NEWS
Investors who lost money with DENTSPLY SIRONA Inc. (NASDAQ: XRAY - GuruFocus
ETF investissant dans des actions DENTSPLY SIRONA, Inc. - TradingView
Dentsply International (XRAY) Expected to Beat Earnings Estimates: Should You Buy? - Eastern Progress
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q1 Earnings Call - Yahoo Finance
Dentsply Sirona stock (US9839191015): Q1 earnings miss and updated FY guidance - AD HOC NEWS
Dentsply Sirona stock (US24906P1093): Updates FY 2026 guidance after Q1 results - AD HOC NEWS
Dentsply Sirona launches AI-enabled diagnostic aid for periapical radiolucencies - Dental Tribune US
Intraoral Radiography Market to Reach USD 3.12 Billion by 2033 as - openPR.com
UBS Group AG Grows Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc. $XRAY Shares Acquired by First Eagle Investment Management LLC - MarketBeat
Cone Beam Computed Tomography Market to Reach USD 1,602 Million - openPR.com
Dentsply Sirona to post Q1 earnings: What's in store for the stock? - MSN
Is Dentsply Sirona (XRAY) Now Offering Value After A 28% One Year Share Price Slide - Sahm
Dentsply Sirona Doubles Down On Digital Dentistry With AI And Wider Reach - Yahoo Finance
Vanguard Group Inc. Has $249.87 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:XRAY) 2026-05-08 - Seeking Alpha
Does Flat Q1 Results Plus New AI Dental Tool Change The Bull Case For DENTSPLY SIRONA (XRAY)? - Sahm
Denture Market 2026- 2033 Overview: Share, Size, Value, Trends, - openPR.com
Dentsply Sirona (XRAY) Narrower Q1 Loss Tests Bullish Margin Recovery Narrative - Sahm
The one question every DENTSPLY SIRONA (XRAY) investor should ask (Modest Decline) 2026-05-06Shared Trade Alerts - newser.com
How DENTSPLY SIRONA (XRAY) margins compare to industry leaders (Grinds Lower) 2026-05-06Trader Community Insights - newser.com
“We must look at the workflow through the dentist’s eyes” - Dental Tribune US
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript - AOL.com
XRAY Stock Down as Q1 Earnings Miss Estimates, Margins Contract - TradingView
Dentsply Sirona stock held at Hold by Needham on execution risk - Investing.com Nigeria
DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $14.00 by Analysts at Mizuho - MarketBeat
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q1 2026 Earnings Call Transcript - Insider Monkey
Dentsply Sirona stock held at Hold by Needham on execution risk By Investing.com - Investing.com India
Dentsply Sirona Q1 2026 slides: flat revenue masks currency headwinds By Investing.com - Investing.com Australia
XRAY Q1 Deep Dive: Revenue Flat as Dentsply Sirona Advances Restructuring and Product Initiatives - The Globe and Mail
DENTSPLY SIRONA Q1 2026 Earnings Call Transcript - MarketBeat
Dentsply Sirona Earnings: Soft Start to the Year Puts More Pressure on the Turnaround Timeline - Morningstar
Dentsply Sirona outlines $3.5B-$3.6B 2026 sales and $1.40-$1.50 EPS while targeting ~$120M annual savings - MSN
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):